Orchid Cellmark Revenue and Competitors
Estimated Revenue & Valuation
- Orchid Cellmark's estimated annual revenue is currently $24.8M per year.
- Orchid Cellmark's estimated revenue per employee is $155,000
Employee Data
- Orchid Cellmark has 160 Employees.
- Orchid Cellmark grew their employee count by -3% last year.
Orchid Cellmark's People
| Name | Title | Email/Phone |
|---|
Orchid Cellmark Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $81.4M | 375 | 40% | N/A | N/A |
#2 | $16.9M | 109 | 22% | N/A | N/A |
#3 | $156.1M | 120 | -70% | $145M | N/A |
#4 | $2.9M | 37 | -24% | $150M | N/A |
#5 | $1.3M | 17 | 0% | $459.5M | N/A |
#6 | $49.2M | 254 | 15% | $180.7M | N/A |
#7 | $7M | 45 | -2% | N/A | N/A |
#8 | $256.3M | 840 | 9% | $168.5M | N/A |
#9 | $10.1M | 65 | 5% | N/A | N/A |
#10 | $16.1M | 104 | 9% | N/A | N/A |
What Is Orchid Cellmark?
Orchid Cellmark has been a leader in the genetic testing field for almost 30 years. Our results come with the guarantee of quality and are delivered with speed, convenience, and most importantly, accuracy—inclusions usually result in 99.99% or 0% probability. Whether you just need to know, or will need results that can be used in a legal matter, Orchid Cellmark should be your first step in this journey.\r\n\r\nOrdering an Orchid Cellmark DNA paternity test can be done easily online at www.orchidcellmark.com or with one phone call to 800-DNA-TEST (362-8378). Our knowledgeable representatives are ready to answer your questions over the phone or via live-chat on our website.
keywords:N/A
N/A
Total Funding
160
Number of Employees
$24.8M
Revenue (est)
-3%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Orchid Cellmark News
... HOLOGIC, Roche, Siemens, Johnson & Johnson, Tecan, Novartis, Diagast, Grifols, Immucor, Innogenetics, Orchid CellMark, Proteome Sciences.
Burlington, North Carolina-based LabCorp’s pursuit of Orchid dates to 2008. In September of that year, LabCorp sent an unsolicited, nonbinding indication of interest to acquire all of the Princeton, New Jersey company’s outstanding stock, according to Orchid regulatory filings. Discussions conti ...
LabCorp in April announced it would acquire Orchid in a deal to boost its identity testing offerings and give the company a presence in the United Kingdom, where Orchid already has operations. The deal was expected to close in May but the Federal Trade Commission asked for more information and L ...
The agreement with the FTC comes eight months after Burlington, North Carolina-based LabCorp announced it would acquire Orchid. The deal was intended to bolster LabCorp’s identity testing offerings while also giving the company a presence in the United Kingdom market, where Princeton, New Jersey ...
Other Companies in
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $35.4M | 160 | -8% | N/A |
#2 | N/A | 160 | 5% | N/A |
#3 | $43.3M | 160 | 8% | N/A |
#4 | $44.2M | 160 | 21% | N/A |
#5 | $40M | 160 | 5% | N/A |